Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC ...

Precision medicine — providing the right treatment, for the right patient, at the right time — is saving lives. The use of therapies that home in on single targets is helping beat tough-to-treat ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor's cancerous cells influence their surroundings, blocking the body's immune defenses and creating a sort of haven ...

Investments in R&D have grown dramatically since 1950, but the number of newly approved drugs has only recently begun to increase. According to a 2018 Deloitte report, returns on research and ...

Digesting danger: A two-decade study exploring the association between food processing and colon cancer. Comparison of screening outcomes associated with advanced precancerous lesion versus colorectal ...